Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
oleh: Violaine Bothy, Maria A. Argudín, Nathalie Olive, Cindy Barbée, Benoît Kabamba-Mukadi, Hector Rodriguez-Villalobos
Format: | Article |
---|---|
Diterbitkan: | Elsevier 2024-03-01 |
Deskripsi
Objectives: In recent years, commercial molecular tools for diagnosis of invasive aspergillosis have emerged, requiring evaluation to ensure quality. Here we assessed the specificity of Aspergillus spp.-ELITe MGB Assay a commercial assay tergeting 18S gene of Aspergillus spp. Design and methods: As part of a method validation, we evaluate the specificity of the Aspergillus spp.-ELITe MGB Assay by testing fourteen culture based samples of sequenced non-Aspergillus fungal species. The benefits of a pre-lysis treatment was evaluated in parallel on serial dilutions of an Aspergillus fumigatus strain. Results: Our findings revealed cross-reactivity in five strains using the 50 copies/mL cut-off recommended by the manufacturer, suggesting potential diagnostic errors and inappropriate management of patients. Pre-lysis treatment does not affect the limit of detection at serial dilution. Conclusions: In conclusion, the Aspergillus spp. ELITe MGB Assay exhibits limited specificity in culture-based samples, underscoring the importance of careful utilization in laboratories. Further studies are warranted to better comprehend of the impact of this cross-reactivity on clinical samples.